We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · September 20, 2018

Fixed-Dose Coadministration of Pramlintide Plus Regular Insulin Shows Promise for Postprandial Hyperglycemia

Diabetes Care


Additional Info

Diabetes Care
Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study
Diabetes Care 2018 Sep 13;[EPub Ahead of Print], MC Riddle, R Nahra, J Han, J Castle, K Hanavan, M Hompesch, D Huffman, P Strange, P Öhman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading